PDEX

PRO DEX INC

Nasdaq · CIK 788920

Last close64.07
Daily change-1.29 (-1.97%)
10 Years gain+1352.83%
Dividends TTM0
Dividend yield0.00%

Fundamental Analysis

PDEX · STANDARD

SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0630

Screener
Fundamental
72.7
Momentum
31.2
Acceleration
18.7
Confidence
92.0
Annual Revenue16
Quarterly Revenue51
Annual CFO15
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth16.8 / 25
Quality14.3 / 25
Capital Efficiency18.2 / 20
Balance Sheet14.4 / 15
Shareholder Economics5.4 / 10
Forward Indicators0.0 / 5

Signals

Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.0272%.

Warnings

Gross margin compression · MEDIUMGross margin compressed by 3.5807 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 3.7598 percentage points.
ROIC declining · MEDIUMROIC declined by 10.9985 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.

Key Metrics

Revenue Growth TTM16.39%OK
Revenue CAGR 3Y18.94%OK
Gross Margin27.78%OK
Operating Margin14.48%OK
FCF Margin9.34%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC23.91%OK
Incremental Operating Margin 3Y18.83%OK
Net Debt / CFO-1.04xOK
Diluted Share Growth 1Y-2.03%OK
SBC / Revenue0.89%OK
SBC / FCF9.54%OK

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2026 FY Jun 30, 2026$77.55M$24.34M$12.99M$7.24M$6.76M31.38%16.75%8.72%19.57%3.32M
2026 FY Jun 30, 2025$66.59M$19.51M$10.69M-$1.68M-$2.93M29.3%16.05%-4.4%19.68%3.36M
2025 FY Jun 30, 2024$53.84M$14.55M$7.17M$6.22Mn/a27.02%13.32%n/a15.18%3.57M
2024 FY Jun 30, 2023$46.09M$12.75M$5.76M$5.46Mn/a27.66%12.5%n/a11.12%3.64M
2023 FY Jun 30, 2022$42.04M$13.13M$5.12M-$847,000.00n/a31.24%12.19%n/an/a3.76M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$74.64Msum latest 4 fiscal quarters RevenueOK0001079973-26-001215, 0001079973-25-001655
Revenue Growth TTM16.39%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0001079973-26-001215, 0001079973-25-001655
Revenue CAGR 3Y18.94%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0001079973-26-001215
Revenue CAGR 5Y15.32%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0001079973-26-001215
Gross Profit CAGR 3Y24.05%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0001079973-26-001215
Operating Income Growth-7.6%OperatingIncome_current / OperatingIncome_prior_year - 1OK0001079973-26-001215, 0001079973-25-001655
FCF Growthn/aFCF_current / FCF_prior_year - 1INSUFFICIENT_HISTORY0001079973-26-001215, 0001079973-25-001655
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin27.78%Gross Profit / RevenueOK0001079973-26-001215, 0001079973-25-001655
Operating Margin14.48%Operating Income / RevenueOK0001079973-26-001215, 0001079973-25-001655
FCF Margin9.34%(CFO - CapEx) / RevenueOK0001079973-26-001215, 0001079973-25-001655
CFO / Net Income0.61xCFO / Net IncomeOK0001079973-26-001215, 0001079973-25-001655
FCF / Net Income0.58xFCF / Net IncomeOK0001079973-26-001215, 0001079973-25-001655
ROIC23.91%NOPAT / Average Invested CapitalOK0001079973-26-001215, 0001079973-25-001655
Net Debt / CFO-1.04xNet Debt / CFOOK0001079973-26-000580, 0001079973-26-001215